Stocktoria

ATOSSA THERAPEUTICS, INC. ATOS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-11-08

ATOSSA THERAPEUTICS, INC. statistics & valuation

Market cap$18.8M
P / B0.5×
Return on equity-88.4%
Return on capital-94.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-205.60% -117.10% -129.50% -131.00% -65.60% -14.90% -22.90% -33.10% -35.70% -88.40% 2016201720182019202020212022202320242025
Shares outstanding
3.8M 2.7M 5.8M 9.1M 47.5M 126.6M 126.6M 126.1M 8.6M 8.6M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-153.70% -99.50% -97.30% -119.00% -41.60% -14.60% -21.80% -31.30% -33.40% -73.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.21 -$0.24 -$3.04 -$4.04 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-73.0%-33.4%-31.3%-21.8%-14.6%-41.6%-119.0%-97.3%-99.5%-153.7%
Return on equity-88.4%-35.7%-33.1%-22.9%-14.9%-65.6%-131.0%-129.5%-117.1%-205.6%
Current ratio5.5314.9917.6121.2345.182.7310.833.966.453.11

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.